The characteristics, importance, and molecular requirements for interactions between mast cells (MCs) and CD8 + T cells have not been elucidated. Here, we demonstrated that MCs induced antigenspecific CD8 + T cell activation and proliferation. This process required direct cell contact and MHC class I-dependent antigen cross-presentation by MCs and induced the secretion of interleukin-2, interferon-g, and macrophage inflammatory protein-1a by CD8 + T cells. MCs regulated antigen-specific CD8 + T cell cytotoxicity by increasing granzyme B expression and by promoting CD8 + T cell degranulation. Because MCs also upregulated their expression of costimulatory molecules (4-1BB) and released osteopontin upon direct T cell contact, MC-T cell interactions probably are bidirectional. In vivo, adoptive transfer of antigen-pulsed MCs induced MHC class I-dependent, antigen-specific CD8 + T cell proliferation, and MCs regulated CD8 + T cell-specific priming in experimental autoimmune encephalomyelitis. Thus, MCs are important players in antigen-specific regulation of CD8 + T cells.
INTRODUCTION
Mast cells (MCs) are well recognized as key effector cells in immunoglobulin E (IgE)-associated immune responses and as prototypic regulators of innate immunity (Marshall, 2004; Metz and Maurer, 2007; Orinska et al., 2007; Galli et al., 2008) . However, evidence that MCs also play an important regulatory role in adaptive immunity is steadily accumulating Stelekati et al., 2007; Sayed et al., 2008) . MCs actively regulate T cell migration. MCs can migrate from the site of allergen encounter to the draining lymph nodes, in which they recruit T cells (Wang et al., 1998) . MCs also recruit T cells at peripheral sites of inflammation by secreting chemotactic molecules, such as MIP-1b, RANTES, and interleukin-16 (IL-16) (Burd et al., 1989; Okumura et al., 2003; Rumsaeng et al., 1997) . MC-derived tumor necrosis factor-a (TNF-a) induces chemotaxis of circulating T cells into the draining lymph nodes during bacterial infection (McLachlan et al., 2003) . Fc3RI-mediated degranulation of MCs results in chemotaxis of effector CD8 + T cells via leukotriene B 4 (LTB 4 ) secretion (Ott et al., 2003) .
CD8
+ T cell recruitment is also induced upon Toll-like receptor 3 (TLR3)-dependent activation of MCs in vivo (Orinska et al., 2005) . Collectively, this evidence suggests that MCs regulate a wide, as yet to be elucidated range of MC-CD8 + T cell functions. The concept that MCs may induce T cell responses initially arose after the observation that cultured MC progenitors and primary MCs (Wong et al., 1982; Banovac et al., 1989) can express surface and intracellular major histocompatibility complex (MHC) class II molecules. Subsequently, MHC class II and expression of costimulatory molecules was detected on mouse, rat, and human MCs. MCs were shown to induce proliferation of CD4 + T cell lines upon presentation of MHC class II-restricted antigens in vitro (Fox et al., 1994; Frandji et al., 1993; Poncet et al., 1999) as well as proliferation of a CD8 + T cell hybridoma line upon phagocytosis of living bacteria (Malaviya et al., 1996) . Costimulatory molecules of the B7 family and the TNF-TNFR families (e.g., 4-1BB and 4-1BBL) were identified on mouse bone marrow-derived MCs (BMMCs) and human primary MCs (Kashiwakura et al., 2004; Nakae et al., 2006) . In vivo, MCs modulate T cell responses in murine experimental autoimmune encephalomyelitis (EAE), the standard animal model for multiple sclerosis, in which both CD8 + T cells and MCs are recognized key players (Secor et al., 2000; Tanzola et al., 2003; Gregory et al., 2005; Sayed et al., 2008) . These findings suggested, but did not prove, that MCs can interact with T cells in an antigen-specific manner. Here, we show that MCs induce CD8 + T cell activation and proliferation, cytokine secretion, and cytotoxicity in an antigen-dependent manner and that, vice versa, this interaction also modulates MC activities.
RESULTS

MCs Present Antigenic Peptides via MHC Class I
We first tested whether MCs are able to take up exogenous peptides, to generate complexes with MHC class I molecules, and to express them on the cell surface (Porgador et al., 1997) . Specific complexes of OT-I peptides and MHC class I molecules (H-2K b ) were indeed recognized by 25-D1.16 antibodies on the surface of BMMCs after preincubation with the model antigenic peptide , SIINFEKL) ( Figure 1A ). This was not seen on BMMCs without peptide preincubation.
In order to probe whether MCs induce CD8 + T cell responses in an antigen-dependent manner, we cocultured OVA 257-264 -loaded BMMCs with T cell receptor-(TCR-) transgenic (OT-I), purified CD8 + T cells at various MC:CD8 + T cell ratios. CD8 + T cell activation was analyzed by flow cytometry. After 48 hr, antigen-pulsed MCs activated CD8 + T cells ( Figure 1B) , as shown by a marked upregulation of the T cell activation markers CD69, CD25, and CD44 on CD8 + T cells. All three T cell activation markers showed the same dynamics with maximal upregulation noted at a 1:2 ratio of MC:CD8 + T cells. However, even at a much lower ratio of MC:CD8 + T cells (1:10), up to 90% ± 4% of CD8 + T cells displayed an activated phenotype (n = 6). The lowest tested ratio of MC:CD8 + T cells = 1:100 still sufficed to induce antigen-specific activation of 29% ± 9% of the CD8 + T cells (n = 6) ( Figure 1B) . Thus, MCs are highly effective activators of CD8 + T cells in vitro. For subsequent experiments, the MC:CD8 + T cell ratio of 1:10 was selected, unless indicated otherwise. When MCs were cultured with CD8 + T cells in the absence of OVA [257] [258] [259] [260] [261] [262] [263] [264] , no CD8 + T cell activation was seen (Figure 1B, control) , demonstrating that the MC-induced CD8 + T cell activation was indeed antigen dependent. In addition, OVA 257-264 -pulsed BMMCs failed to activate primary purified CD8 + T cells from wild-type (WT) mice (data not shown), indicating that activation of CD8 + T cells by MCs was antigen specific.
To explore whether the observed MC-T cell interaction depends on the expression of MHC class I on MCs, we used BMMCs derived from beta-2-microglobulin (b 2 m)-deficient (B2m À/À ) mice, which do not express functional MHC class I (Zijlstra et al., 1990) , for coculture with CD8 + T cells. Compared to MHC class I-competent WT MCs, the B2m À/À MCs induced only a minimal activation of CD8 + T cells (4.6% ± 2.1%, n = 4), with CD69, CD25, and CD44 surface expression as activation markers ( Figure 1B ). This indicates that the bulk of CD8 + T cell activation induced by MCs was due to antigen presentation via functional MHC class I molecules. Next, we examined the proliferation of CD8 + T cells by incubating OVA 257-264 -pulsed MCs with CFSE-labeled OT-I T cells. Maximal proliferation was detected at a ratio of MC:CD8 + T cells = 1:20, with 92% ± 2% (n = 3) ( Figure 1C ). At the lowest tested ratio (1:100), a total of 57% ± 17% (n = 4) of the CD8 + T cells still was in the proliferation pool, whereas no T cell proliferation was detected in the presence of unpulsed MCs or with B2m À/À , OVA 257-264 -pulsed MCs ( Figure 1C ). Thus, MCs induced antigen-specific proliferation of CD8 + T cells in an MHC class I-dependent manner.
MC-CD8
+ T Cell Coculture Stimulates Cytokine and MIP-1a Release by CD8 + T Cells
Because the secretion of defined cytokines is a key effector function of activated CD8 + T cells, we investigated the cytokine milieu generated upon antigen-dependent MC-CD8 + T cell contact in vitro. High amounts of IL-2, IFN-g, and MIP-1a (Figure 2A ), as well as lower amounts of TNF-a (0.31 ± 0.18 ng/ml) (n = 3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) (0.4 ± 0.12 ng/ml) (n = 3) (data not shown), were measured in supernatants after antigen-specific MC-CD8 + T cell contact. In contrast, hardly any or no production of IL-4, IL-5, IL-10, and IL-12 was seen (data not shown). IL-2, IFN-g, TNF-a, and MIP-1a were detected intracellularly in CD8 + T cells upon MC-mediated antigen-dependent activation ( Figure S1 available online), at a percentage of 5.5% ± 2.9% (n = 10), 3.1% ± 1.5% (n = 10), 7.5% ± 0.57% (n = 4), and 19.3 ± 8.7% (n = 3) respectively. Furthermore, when Figure S2 ). However, this was associated with augmented concentrations of IL-6 and IL-13 in the supernatants, whereas those of IL-2 and IFN-g remained unchanged ( Figure 2A ). Therefore, despite stimulation of a classical MC activation pathway associated with the production of Th2 cell-type cytokines, the CD8 + T cell response remained skewed toward a Th1 cell-type secretory response pattern. (Orinska et al., 2005) . Therefore, we hypothesized that the exposure of MCs to TLR ligands might modulate the capacity of MCs to activate CD8 + T cells. We found that TLR-activation of MCs by LPS or poly I:C enhanced the capacity of MCs to activate CD8 + T cells and to increase both MC surface expression of MHC class I molecules and their IL-2 cytokine secretion ( Figure S3 ). Thus, invading pathogens may enhance the MHC class-I dependent antigen presentation of resident MCs.
TLR Ligands
Contact with Antigen-Specific MCs Enhances CD8 + T Cell Cytotoxic Potential and Degranulation
The amount of granzyme B (Gzmb) in CD8 + T cells upon interaction with antigen-presenting MCs was analyzed by flow cytometry as an indicator of CD8 + T cell-mediated cytotoxicity. Intracellular Gzmb expression was increased by 27% ± 9% (n = 9) in CD8 + T cells after antigen-mediated activation by MCs, a prerequisite for subsequent efficient cytolytic T cell activities (Figure 2C) . Next, we examined whether CD8 + T cell exocytosis was enhanced by measuring surface expression of lysosomal-associated membrane protein-1 (LAMP-1) on CD8 + T cells after activation by MCs (Burkett et al., 2005) . Indeed, CD8 + T cells showed markedly increased surface LAMP-1 expression after activation with antigen-pulsed MCs ( Figure 2C ). Thus, at least in vitro, BMMCs increased the cytotoxic potential of CD8 + T cells by increasing their intracellular content of Gzmb and by inducing their degranulation in an antigen-specific manner.
Direct Cell-Cell Contact Is Essential for AntigenDependent MC-CD8 + T Cell Interaction
To further dissect the mechanistic requirements for antigenspecific MC-CD8 + T cell interactions, we investigated whether direct cell-contact is essential for CD8 + T cell activation by
MCs. OVA 257-264 -pulsed MCs were cultured in free cell contact with CD8 + T cells or in the presence of two kinds of semipermeable membranes: one that allows the passive diffusion of any soluble factor (0.2 mm anopore membrane) or one (0.02 mm membrane) that excludes the diffusion of exosomes. Both types of membranes completely abrogated the subsequent activation (upper and middle row) and proliferation (lowest row) of CD8 + T cells. This documented the necessity of direct cell-cell contact between MCs and CD8 + T cells for activation and proliferation of CD8 + T cells ( Figure 2D ). Although our data do not question the principle that MCs can regulate the phenotype and function of adaptive immune cells by releasing exosomes loaded with specific antigens (Skokos et al., 2003) , our current results suggest that soluble factors (including exosomes) alone are insufficient to induce antigen-specific activation of CD8 + T cells by MCs.
MCs Induce Antigen-Specific CD8 + T Cell Responses upon Listeria monocytogenes Infection
MCs play a dominant role in various host defense mechanisms Galli et al., 2008) . To explore whether MCs can stimulate CD8 + T cell responses upon infection with intracellular bacteria, we infected BMMCs with Listeria monocytogenes. BMMCs could be infected by L. monocytogenes at multiplicity of infection rates of 1:1 to 100:1 ( Figure S4 ). To investigate potential CD8 + T cell responses induced by MCs upon their infection by L. monocytogenes, we used recombinant L. monocytogenes-OVA (Foulds et al., 2002) . BMMCs were infected with L. monocytogenes-OVA, extracellular bacteria were killed with gentamycin, and the MCs were coincubated with purified OT-I T cells. BMMCs that had been infected with L. monocytogenes-OVA activated CD8 + T cells, as
shown by increased CD69 and CD25 surface expression (21.6% ± 12.7%, n = 5) ( Figure 3A ). This was in striking contrast to L. monocytogenes-infected BMMCs and to untreated BMMCs (control), which failed to activate the transgenic CD8 Figure 3A) . Thus, the antigen-specific activation and proliferation of CD8 + T cells induced by L. monocytogenes-OVA-infected MCs was MHC class I dependent. These results demonstrate that MCs can internalize, process, and present bacterial antigens and thus induce antigen-specific activation and proliferation of CD8 + T cells. Figure S7B ).
As shown in Figure 5A and Figure 5A and Table 1 ). Histochemistry of CNS ( Figure 5B ) and spinal cord (data not shown) 27 days after immunization revealed a comparable focal inflammatory cell infiltration between WT and WT BMMCs-reconstituted W sh /W sh mice. Twenty-seven days after immunization, brains and spinal cords were recovered and infiltrating cell subsets were analyzed by flow cytometry. The absolute numbers of infiltrating cells ( Figure 5C ), namely the absolute numbers of CD8 + , but not of CD4 + T cells, were consistently and significantly reduced in W sh /W sh mice ( Figure 5D ), whereas reconstitution with WT BMMCs fully restored the CD8 + T cell number. This was confirmed upon MOG 35-55 peptide in vitro rechallenge of splenocytes and measured by IFN-g production (data not shown).
These results demonstrated that BMMCs are not only able to restore the clinical disease phenotype and severity in MC-deficient mice but also specifically reconstitute the impaired CD8 + T cell response of MC-deficient mice.
CD8 + T Cell-MC Interactions Are Bidirectional
Although we had shown that MCs modulate CD8 + T cell responses, it remained unclear whether activated CD8 + T cell Figure 6A ). Furthermore, PCR analysis performed on the cDNA of purified MCs after antigen-dependent coculture with CD8 + T cells revealed a substantial upregulation of 4-1BB ( Figure 6B ). This shows that CD8 + T cells responded to their activation by MCs not only by upregulating the MHC expression on MCs but also by stimulating 4-1BB expression on MCs. MCs secrete biologically active osteopontin (OPN) (Nagasaka et al., 2008) , which plays an important role in regulating T cell responses during inflammation and infection (Hur et al., 2007) . Therefore, we finally examined whether OPN is produced by MCs upon contact with (Malaviya et al., 1996) . These observations encouraged us to address whether MCs are capable of inducing antigen-specific CD8 + T cell responses in vivo and to characterize the underlying mechanisms of MC-CD8 + T cell 
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Antigen-Specific Mast Cell-CD8 T Cell Crosstalk interactions, the phenotypical and functional consequences of these interactions, and thus the bidirectionality of this communication.
Testing two distinct, well-characterized model antigens (OVA and MOG), we demonstrated here that MCs induce antigenspecific CD8 + T cell activation and proliferation in vitro and in vivo. OVA 257-264 peptide was utilized as a model antigen for studying antigen-presenting functions of different cell types in vitro (Rü ckert et al., 2003; Winau et al., 2007) .
The antigen-specific CD8 + T cell response after contact with (Schott et al., 2002; Su et al., 1993) . MCs also induced CD8 + T cell effector functions, such as the production of key T cell cytokines, IFN-g and IL-2, but none of the Th2 cell-associated cytokines examined (IL-4, IL-5, and IL-10).
Our data confirm and extend the previous proposal that MCs play a dual, complex role in regulating the Th1-Th2 cell cytokine milieu and operate as either predominantly immunosuppressive or immuno-stimulatory cells, depending on the local signaling milieu and/or the strength of costimulatory signals and/or specific signals from the T helper cell environment of MCs (Gregory and Brown, 2006; Stelekati et al., 2007) . Our study highlights that, besides their role as inducers of Th2 cell responses through the release of IL-4 (Mekori and Metcalfe, 1999) , MCs can also favor Th1 cell responses via interaction with CD8 + T cells and induction of IFN-g and IL-2 production. The latter is potentiated via MC prestimulation by TLR ligands but unaffected by Fc3RI stimulation. This suggests that the stimulation of resident peripheral tissue MCs by pathogen-associated TLR ligands may quickly and effectively promote Th1 cell-type, CD8 + T celldependent anti-infection defense against such pathogens. These data conform with the central role of IFN-g in CD8 + T cell cytolytic activity (Andersen et al., 2006) . In addition, we show that the intracellular content of Gzmb, a key component of the (C) The concentration of OPN in the supernatants of MC-CD8 + T cell cocultures was measured by ELISA.
Graph shows mean values ± SEM of four independent experiments with at least eight different BMMC cultures.
Antigen-Specific Mast Cell-CD8 T Cell Crosstalk cytolytic machinery of CD8 + T cells, increases in CD8 + T cells after antigen-specific activation by MCs and that CD8 + T cells degranulate upon antigen presentation by MCs. This concept is in line with the observation that MC-deficient mice fail to initiate peptide-specific cytotoxic responses upon TLR7 activation in vivo (Heib et al., 2007) . The MC-dependent CD8 + T cell responses revealed here could be important for an optimized host defense, such as protection against intracellular bacteria, because MCs can induce, e.g., activation and proliferation of CD8 + T cells upon infection with L. monocytogenes. MCs mount an early defense against L. monocytogenes by rapid release of TNF-a and by stimulation of neutrophil migration to the site of infection (Gekara and Weiss, 2008) . Our data suggest that MCs can, in addition, directly induce effector CD8 + T cell activities geared at eliminating intracellular pathogens like Listeria.
We showed that MC-CD8 + T cell interactions also occur in vivo. Adoptive transfer of antigen-loaded MCs and OT-I transgenic CD8 + T cells into B2m À/À mice served as a model in which efficient, endogenous MHC-I-restricted antigen presentation is excluded, thus eliminating a contribution of other resident APCs to the antigen-dependent CD8 + T cell responses. Furthermore, we provided direct evidence that MCs control disease severity and contribute to CD8 + -specific priming in EAE and showed that the T cell-proliferation failure is specific to CD8 + .
Our finding that MCs control EAE disease severity in W sh /W sh support corresponding findings in W/W v mice (Secor et al., 2000; Tanzola et al., 2003; Gregory et al., 2005) , but disagree with the claim that EAE in W sh /W sh is indistinguishable from EAE in WT mice (Bennett et al., 2009) . That MCs can induce the proliferation of primary CD8 + T cells in an antigen-dependent and antigen-specific manner in vivo supports the concept that MCs function as crucial switchboard cells between innate and adaptive immunity and thereby profoundly modulate adaptive immune responses Stelekati et al., 2007; Sayed et al., 2008) and begs the question of whether MCs have similar functions in the human system. Because the majority of MCs resides at peripheral tissue sites (Marshall, 2004; Galli et al., 2008) , upon encountering pathogen-related antigens, MCs may internalize the latter to serve as a strategically placed peripheral reservoir for the presentation of pathogen-related antigenic peptides. Indeed, MCs latently infected by human immunodeficiency virus (HIV) constitute a long-lived, inducible peripheral reservoir of viral antigens in humans (Sundstrom et al., 2007) . Some MC subpopulations may migrate to regional lymph nodes upon infection or inflammatory stimuli (Dabak et al., 2004; Wang et al., 1998) . However, we hypothesize that, in contrast to DCs, which normally execute their antigen-presenting functions in regional lymph nodes, it is primarily resident MCs that play an important, previously unappreciated role in the control of CD8 + T cell responses in infection-prone peripheral tissues. Our study suggests that MCs constitute part of a growing family of nonclassical, functionally important tissue-or microenvironment-specific APCs that complements ''professional'' APCs (DCs, B cells, and macrophages), such as epithelial cells, fibroblasts, and hepatic stellate cells (Unanue, 2007) . Furthermore, our data indicate that MC-CD8 + T cell interactions are bidirectional: CD8 + T cells also enhance surface MHC class I and induce 4-1BB expression on MCs as well as the production of OPN after antigen-dependent interaction. The upregulation of 4-1BB, a costimulatory molecule that promotes proliferation and effector functions of T cells (Hurtado et al., 1995) , after antigen-dependent MC contact with CD8 + T cells provides mechanistic pointers. MCs can express 4-1BB (Nakae et al., 2006) , and 4-1BB-mediated stimulation of MCs enhances cytokine production (Nishimoto et al., 2005) . Therefore, increased 4-1BB expression on MCs may enhance the required production and release of cytokines and other soluble factors by MCs. However, it remains to be definitively clarified whether the upregulation of MHC I and 4-1BB on MCs is primarily caused by secreted, T cell-derived factors (e.g., IL-2, IFN-g) and/or by cell-cell contact-dependent mechanisms. Finally, we showed here that OPN, a key cytokine that supports T cell survival and responses (Hur et al., 2007) and is produced by MCs upon Fc3RI stimulation (Nagasaka et al., 2008) , is upregulated and secreted by MCs upon antigen-dependent MC-CD8 + T cell interactions. Therefore, the bidirectional crosstalk between MCs and CD8 + T cell may not only support CD8 + T cell effector functions and cytotoxicity but also regulate CD8 + T cell survival.
In summary, we showed that MCs regulate antigen-specific responses of primary CD8 + T cells in vitro and in vivo in a bidirectional and cell-cell contact-dependent manner. This MC function is likely to be important in all scenarios in which effector CD8 + T cells are critically involved, e.g., infections with viruses and other intracellular pathogens and/or CD8 + T cell-dependent autoimmune diseases such as, e.g., multiple sclerosis, alopecia areata, and type I diabetes (Gregory et al., 2005; Gilhar et al., 2007; Sayed et al., 2008) . It now deserves systematic scrutiny whether, in these settings, the stimulation or inhibition of MC-CD8 + T cell interactions offers a promising new target for more effective therapeutic management.
EXPERIMENTAL PROCEDURES Animals C57BL/6 WT mice were purchased from Charles River (Sulzfeld). TCR-transgenic OT-I mice (Hogquist et al., 1994) and Il2 À/À mice (Schorle et al., 1991) were bred in the Animal Care Facility of the Research Center Borstel. B2m
mice (Koller and Smithies, 1989) 
Generation of BMMCs and BMDCs
Murine bone marrow cells were cultivated in IMDM complete medium with 10% FCS (Biochrom), 5 ng/ml IL-3 (rIL-3), and 10 ng/ml stem cell factor (rSCF) (both from R&D) (Huff and Lantz, 1997) . represented >98% of the total cells. BMDCs were generated by cultivation of bone marrow cells in the presence of GM-CSF as described (Lutz et al., 1999 Intracellular flow cytometry staining was performed in accordance with a standard protocol from eBioscience. After 6 hr of cell culture with 10 mg/ml brefeldin A (Sigma), cells were washed and surface FACS staining was performed. After fixation and permeabilization, intracellular staining was performed by incubation with mAb against IL-2 (JE96-5H4), IFN-g (XMG1.2), and TNF-a (MP6-XT22) (BD PharMingen), MIP-1a (R&D Systems), or Gzmb (16G6) (eBioscience). All plots were gated on propidium iodide-negative CD8 + T cells.
Purification and Coculture of CD8 + T Cells, MCs, and Macrophages CD8 + T cells were isolated from lymph nodes of OT-I TCR-transgenic mice by negative selection with magnetic-associated cell sorting (MACS). Cells were stained with FITC mAb against CD4, CD45R/B220, CD49b/Pan-NK, CD11c, CD11b, and F4/80, washed, incubated with magnetic anti-FITC-labeled microbeads (Miltenyi Biotec), and sorted with autoMACS (Miltenyi Biotec). The sorting yielded >98% CD8 + T cells.
For purification of MCs after the in vitro coculture with CD8 + T cells, magneticassociated positive selection was used. Cells were incubated with biotinlabeled c-kit specific mAb, washed, incubated with streptavidin-micobeads, and selected with autoMACS. The purity of the MC fraction was >98%, as shown by CD117, T1/ST2, and Fc3RI expression, determined by FACS. Peritoneal cells from WT mice were isolated by peritoneal lavage with 10 ml of ice-cold 0.9% NaCl solution. Peritoneal mast cells (PMCs) were selected in a FACS sorter (FACS Aria, BD Biosciences) in accordance with their expression of CD117 and T1/ST2. Purity of PMCs was >98%, according to toluidine blue staining.
Primary macrophages were selected from cells of peritoneal lavage by adherence to tissue type cell culture plates for 2 hr. Nonadherent cells were washed away and macrophages stimulated in vitro with 20 mg/ml OVA before the CD8 + T cells at a ratio MF:CD8 1:10 were added.
MCs were incubated with 4 mg/ml OVA 257-264 (NeoMPS) for 3 hr or with 100 mg/ml OVA (OVA grade VI, Sigma) for 8 hr at 37 C and washed four times.
OVA 257-264 was tested for endotoxin activity by Coamatic Chromo-LAL kit (Hemochrom Diagnostica, Essen, Germany) with a resolution limit of 0.005EU/ml. These were in a range of 0.6-0.7EU/ml corresponding to 40-47 pg/ml. Furthermore, the TLR2 agonistic activity of the OVA 257-264 peptide was measured by induction of IL-8 production in cells transiently transfected with TLR2 as described (Heine et al., 2007) , and this was lower than 0.1 nM TLR2 agonist Pam 3 CSK 4 . CD8 + T cells were plated at a density of 2 3 10 6 cells/ml and BMMCs were added at different ratios. In some experimental conditions, the BMMCs were pretreated overnight with 2 mg/ml of IgE (SP7, Sigma) before OVA 257-264 loading and then the IgE-presensitized BMMCs were cultured in the presence of Ag 100 ng/ml (DNP-HSA, Sigma). For proliferation assays, CD8 + T cells were labeled with 3 mM CFSE (Vybrant CFDA SE. Cell Tracker Kit, Molecular Probes) for 6 min at room temperature. The reaction was stopped by addition of FCS, cells were washed, and proliferation was measured by FACS 72 hr later. Concentrations of cytokines were determined by specific ELISAs provided by R&D Systems.
Infection of BMMCs with Listeria monocytogenes
WT Listeria monocytogenes (strain EGD) or recombinant strain Listeria monocytogenes-OVA (Foulds et al., 2002) were cultured overnight, and bacterial density was determined by absorption at 600 nm. BMMCs were washed and resuspended in IMDM complete medium without antibiotics, at a concentration of 1 3 10 6 cells/ml. Listeria monocytogenes or Listeria monocytogenes
OVA were added at a MOI of 1:1-100:1 for 1 hr at 37 C. Next, 50 mg/ml gentamycin (GIBCO-Invitrogen) was added to the BMMCs for 30 min, and BMMCs were washed three times and cocultured with the CD8 + T cells in IMDM medium containing 10 mg/ml gentamycin.
Adoptive Transfer Experiments
A total of 5 3 10 6 BMMCs were incubated with 4 mg/ml OVA 257-264 for 3 hr at 37 C and after four washings were injected intraperitoneally in WT or B2m À/À mice. One day later, purified OT-I CD8 + T cells were labeled with CFSE and injected in the peritoneum of recipient mice (8 3 10 6 cells/mouse). Four days later, proliferation of transgenic CD8 + T cells was analyzed by CFSE dilution.
EAE Induction, Clinical Score, and Histological Analysis EAE was induced in mice by injection subcutaneously in both flanks with a total of 200 mg of MOG 35-55 peptide (MEVGWYRSPFSRVVHLYRNGK) (NeoMPS) dissolved in PBS emulsified in an equal volume of CFA (Difco) supplemented with 4 mg/ml Mycobacterium tuberculosis H37RA (Difco). Mice were injected twice intravenously with 300 ng of pertussis toxin (Calbiochem) administered on the day of immunization and 48 hr later. Mice were scored daily as follows: 0, no detectable signs of EAE; 0.5, distal limb tail; 1.0, complete limb tail; 1.5, limb tail and hind-limb weakness; 2, unilateral partial hind-limb paralysis; 2.5, bilateral partial hind-limb paralysis; 3, complete bilateral hind-limb paralysis; 3.5, complete hind-limb paralysis and unilateral forelimb paralysis; 4, total paralysis of forelimbs and hind limbs; and 5, death. Immunohistochemical stainings were carried out as described (Kellner et al., 2009) . In brief, paraffin-embedded sections from brain were stained with hematoxylin eosin (H&E), giemsa, or immunostaining to T cells (CD3, Dako) and B cells (B220, E-Bioscience), with horseradish peroxidase-labeled secondary antibodies (Nichirei) and diaminobenzidine as chromogen. For the preparation of CNS lymphocytes, mice were perfused through the left cardiac ventricle with PBS. Afterward, brain and spinal cord were removed and incubated 30 min in a digestion solution (1 mg/ml collagenase and 0.1 mg/ml DNase from Sigma-Aldrich). Subsequently, the digested tissue was transferred on a cell strainer and the RBCs were lysed. CNS mononuclear cells were isolated by a Percoll gradient (1.095 g/ml-1.030 g/ml) from GE-Healthcare. The isolated cells were washed and resuspended in staining buffer for a direct cell-surface staining.
Ag Recall Proliferation
Seven days after immunization, mice were sacrificed and spleens were removed. For the T cell stimulation in vitro, BMDCs and BMMCs were preloaded with 5 mM of MOG 35-55 peptide for 2 hr at 37 C and then CFSE-labeled CD8 + T cells or splenocytes were added at a ratio 1:10. After 3 days, the cells were washed and cultured for 2 days in 50 ng/ml of recombinant IL-2. The proliferation was measured by FACS. 
Real-Time PCR
Statistical Analysis
Data are represented as mean ± standard deviation (SD) or standard error of mean (SEM) as indicated. Statistical significance was tested by Student's t test for unpaired samples. A p value of < 0.05 was considered as statistically significant.
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